Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia.

Brown D, Daniels K, Pichereau S, Sand M
Neurol Ther. 2017 Nov 24. PMID: 29177699. Pubmed